抗体
试剂盒
多肽
蛋白
组织芯片
产品中心
Product Center
Research Grade Quisovalimab
All
TD-HT145016_1.jpg
- Catalog： TD-HT145016
- Clonality： mAb
- Application： Research Grade Biosimilar
- Synonyms： AEVI-002,CERC-002,F-19,MDGN-002,SAR-252067CAS:2427667-03-4
-
规格：
1mg
-
价格：
¥询价
定制服务咨询
Research Grade Quisovalimab
| Catalog No. | TD-HT145016 |
|---|---|
| Species reactivity | Human |
| Applications | Research Grade Biosimilar |
| Host species | Human |
| Isotype | IgG4-kappa |
| Expression system | Mammalian Cells |
| Clonality | Monoclonal |
| Target | Herpes virus entry mediator ligand, LIGHT, CD258, HVEM-L, HVEML, TNFSF14, Tumor necrosis factor ligand superfamily member 14, Herpesvirus entry mediator ligand |
| Endotoxin level | Please contact the lab for this information. |
| Purity | >95% purity as determined by SDS-PAGE. |
| Purification | Protein A/G, purified from cell culture supernatant. |
| Accession | O43557 |
| Form | Liquid |
| Storage buffer | 0.01M PBS,pH7.4. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternate Names | AEVI-002,CERC-002,F-19,MDGN-002,SAR-252067CAS:2427667-03-4 |
| Background | Quisovalimab (AVTX-002; AEVI 002; SAR 252067) is a human monoclonal antibody against LIGHT, a tumor necrosis factor (TNF)-related cytokine (TNFSF14) that plays an important role in acute respiratory distress syndrome (ARDS) and cytokine release syndrome (CRS) COVID-19. Quisovalimab can be used in COVID-19 acute respiratory distress syndrome and other studies. |
| Note | For research use only. Not for use in clinical or therapeutic applications. |
|
|
SEC-HPLC detection for Research Grade Quisovalimab. |